@scadsfct

New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology

, , , , , , , , , and . npj Precision Oncology, (January 2024)
DOI: 10.1038/s41698-024-00517-w

Links and resources

Tags